ProAct, Inc., is proud to have been awarded the 2024 Excellence Award for Clinical Innovation for Clinical Optimization by the Pharmacy Benefit Management Institute (PBMI) for our Clinical Optimization Program.
“The Clinical Optimization Program is an innovative approach to managing employer spend while improving our members’ health outcomes,” said Deborah Dempsey, MBA, Pharm.D., RPh, ProAct’s Chief Operating Officer. “Through targeted interventions and pharmacist-directed comprehensive medication reviews, ProAct’s Clinical Pharmacists identify gaps in care, lower cost therapeutically equivalent alternatives, drug winteractions, and duplication of therapies. ProAct understands that not only is it important to our plan sponsors to lower plan spend but to also improve the health of our members.”
About PBMI
The Pharmacy Benefit Management Institute is the industry's only membership organization exclusively dedicated to helping healthcare purchasers maximize the value of their drug benefit plans. Since 1995, PBMI has provided valuable research, education, web resources, and a forum to advance best practices and drive marketplace changes that improve pharmacy benefits and control costs.
About ProAct, Inc.
ProAct, Inc., is a 100% employee-owned pharmacy benefit management (PBM) company. ProAct is a part of the KPH Healthcare Services family of companies, which includes Kinney Drugs. ProAct empowers clients to take charge of their pharmacy benefit plans by combining high-touch service with the latest in PBM technology. ProAct manages the dispensing of prescription drugs through its mail order pharmacy, ProAct Pharmacy Services, as well as through its national retail pharmacy network consisting of over 64,000 pharmacies in the United States, Puerto Rico, Guam, and the Virgin Islands. For more information, visit www.proactrx.com.
Media Contact
Amanda Pendock
Senior Marketing Lead
amandapendock@proactrx.com
